Home › Funds › Kingsbury Capital Investment Advisors LLC › INTS

Kingsbury Capital Investment Advisors LLC position in INTS

INTENSITY THERAPEUTICS INC · Health Care

Kingsbury Capital Investment Advisors LLC reported holding 706,523 shares of INTS (INTENSITY THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$2.4M, representing 2.25% of its reported portfolio and ranking #7 among its reported holdings. Kingsbury Capital Investment Advisors LLC has disclosed INTS holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

Latest position (Q3 2026)706.52K sh
Reported value held$2.38M
Portfolio Weight2.25%
First reportedQ1 2026
Last changeAdd
Updated2026-10-20

Last updated: 2026-10-20 · Source: SEC EDGAR Form 13F-HR

How Kingsbury Capital Investment Advisors LLC's INTS position evolved

Kingsbury Capital Investment Advisors LLC first disclosed a stake in INTS in Q1 2026 at 38,054 shares (US$224K). The position peaked in Q3 2026 at 706,523 shares, worth US$2.4M. Across 3 filings, Kingsbury Capital Investment Advisors LLC increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 706,523 shares valued at US$2.4M — an increase of 210,030 shares quarter over quarter.. Notable position changes include a 1205% increase in Q2 2026 (shares fell 18% over the following quarter), a 42% increase in Q3 2026 (shares were roughly flat over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2026 38.05K $223.76K New
Q2 2026 496.49K $2.04M Add
Q3 2026 706.52K $2.38M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About INTS and 13F data

INTS (INTENSITY THERAPEUTICS INC) is a Health Care company. 17 other funds we track also report a position in INTS — the largest reported positions include KMT WEALTH MANAGEMENT, LLC (US$2.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding INTS

All INTS fund holders →

FAQ

How long has Kingsbury Capital Investment Advisors LLC held INTS?

Kingsbury Capital Investment Advisors LLC has disclosed INTS holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

What is Kingsbury Capital Investment Advisors LLC's current position in INTS?

As of Q3 2026, Kingsbury Capital Investment Advisors LLC holds 706.52K shares of INTS (INTENSITY THERAPEUTICS INC), valued at $2.38M, representing 2.25% of its reported portfolio and ranking #7.

Has Kingsbury Capital Investment Advisors LLC been buying or selling INTS?

In the latest 13F filing (Q3 2026), Kingsbury Capital Investment Advisors LLC increased its position in INTS. The position peaked in Q3 2026 at 706.52K shares.

Which other funds hold INTS?

Other major institutional holders of INTS include KMT WEALTH MANAGEMENT, LLC, among 17 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.